PRESS RELEASE published on 04/29/2025 at 22:15, 11 months 23 days ago REMINDER: Jaguar Health Hosting April 30 Investor Webcast to Present Initial Results from Proof-of-Concept Study of Crofelemer for the Rare Diseases Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome with Intestinal Failure (SBS-IF) Jaguar Health investor webcast to review crofelemer impact on MVID and SBS-IF patients. No approved treatments for MVID, study presented by Dr. Miqdady at ELITE PED-GI Congress Investor Webcast Jaguar Health MVID SBS-IF Crofelemer Impact
PRESS RELEASE published on 04/29/2025 at 22:05, 11 months 23 days ago Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis Abivax completes enrollment for Phase 3 ABTECT Trials in patients with active ulcerative colitis. Top-line results expected in Q3 2025, NDA submission planned for H2 2026 Abivax Ulcerative Colitis Phase 3 ABTECT Trials NDA Submission
PRESS RELEASE published on 04/29/2025 at 21:10, 11 months 23 days ago GENFIT Announces Publication of the 2024 Universal Registration Document and the 2024 Annual Report on Form 20-F GENFIT announces filing of 2024 Universal Registration Document and Annual Report on Form 20-F with AMF and SEC, available for public viewing and download. Details of reports and company's focus on liver disease research and development highlighted 2024 Universal Registration Document Form 20-F Liver Diseases GENFIT
PRESS RELEASE published on 04/29/2025 at 21:00, 11 months 23 days ago RUM Reports Annual Financial Results for the Year Ended December 31, 2024 Rocky Mountain Liquor Inc. reports financial results for FY 2024. Improved margins, mixed year-end results, modernized POS system rollout, committed to enhancing value for customers in 2025 Financial Results Rocky Mountain Liquor Inc. Customer Value 2025 Outlook POS System
PRESS RELEASE published on 04/29/2025 at 21:00, 11 months 23 days ago Inside Information / Other news releases Innate Pharma presents preclinical data for IPH4502, a Nectin-4 targeting ADC, showing superior anti-tumor efficacy in multiple cancer models at AACR 2025 Annual Meeting Preclinical Data Innate Pharma IPH4502 AACR 2025 Nectin-4 ADC
PRESS RELEASE published on 04/29/2025 at 20:57, 11 months 23 days ago EQS-Adhoc: aap Implantate AG: Postponement of the publication of the annual financial statements and consolidated financial statements for the financial year 2024 aap Implantate AG postpones the publication of its 2024 annual and consolidated financial statements due to auditor delay and resource constraints. New deadline set for June 2025 Financial Statements 2024 Aap Implantate AG Postponement Auditor Delay
PRESS RELEASE published on 04/29/2025 at 19:55, 11 months 23 days ago Adcore Announces Voting Results from Annual and Special Shareholders Meeting Adcore Inc. announces election of five directors at the annual meeting. Company offers AI-powered marketing technology for digital advertising Digital Marketing Adcore Inc. AI-powered Technology Annual Meeting Director Election
PRESS RELEASE published on 04/29/2025 at 19:53, 11 months 23 days ago EQS-Adhoc: Gateway Real Estate AG is postponing publication of the audited consolidated financial statements 2024 Gateway Real Estate AG postpones the publication of the audited consolidated financial statements for 2024 due to ongoing negotiations. New date expected in June 2025 2024 Negotiations Postponement Audited Financial Statements Gateway Real Estate AG
PRESS RELEASE published on 04/29/2025 at 19:22, 11 months 23 days ago Funding Circle Holdings plc: POS-Transaction in Own Shares Funding Circle Holdings plc announces buyback of 194,884 Ordinary Shares, with highest price at 113.80p and lowest at 111.60p, to be canceled for a total of 314,587,114 shares outstanding London Stock Exchange Ordinary Shares Cancellation Buyback Funding Circle Holdings PLC
PRESS RELEASE published on 04/29/2025 at 19:07, 11 months 23 days ago EQS-Adhoc: Hypoport SE: Significant Increase in Revenue and EBIT in Q1 2025 Hypoport SE reports significant increase in revenue (+20%) and EBIT (+85%) in Q1 2025, mainly driven by private mortgage business growth. Final results to be released on May 12, 2025 Revenue Increase Hypoport SE EBIT Increase Q1 2025 Mortgage Business
Published on 04/23/2026 at 18:00, 22 minutes ago Gold Port Renews Groete Project Mining Permit; Advances Camp Reconstruction
Published on 04/23/2026 at 16:20, 2 hours 2 minutes ago CORRECTION FROM SOURCE: Avino Announces Q1 2026 Production Results
Published on 04/23/2026 at 15:00, 3 hours 22 minutes ago Critical Elements Announces the Results from The Annual Meeting of Shareholders
Published on 04/23/2026 at 14:30, 3 hours 52 minutes ago Klondike Gold Engages Fundamental Research Corp. for Analyst Coverage
Published on 04/23/2026 at 14:30, 3 hours 52 minutes ago Hillcrest Energy Technologies Finalizes A-Sample Design of ZVS PCS1000 Sidecar Power Unit for Next-Generation AI Data Centers
Published on 04/23/2026 at 18:00, 22 minutes ago Oxford Royale Academy Partners with MIT to Bring AI Education to Summer School Students
Published on 04/23/2026 at 18:00, 22 minutes ago Sales data for the first quarter of 2026: FORVIA HELLA starts the new fiscal year with solid sales performance
Published on 04/23/2026 at 17:40, 42 minutes ago VALBIOTIS SA: Valbiotis expands its e-commerce to Belgium and Luxembourg
Published on 04/23/2026 at 18:18, 4 minutes ago Aéroports de Paris SA - Sale by Groupe ADP of securities representing 3.4% with option to sell an additional 3.9% of GAL's equity share capital to GMR Group
Published on 04/23/2026 at 18:00, 22 minutes ago 2025 Full-Year Results: Strong Top-Line Rebound (+26%)
Published on 04/23/2026 at 17:50, 32 minutes ago Cegedim: Like-for-like revenues fell 0.8% in the first quarter of 2026